drugset
drugset / Trial / NCT01240954

Comparison of Different Up-dosing Schedules With Osiris

NCT01240954 ↗

Phase 2 Terminated 210 enrolled ALK-Abelló A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare different up-dosing schedules with Osiris.

Timeline

Start
2010-12
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “CA approval not obtained”

Drugs

EvaluationDrugModalityDoseRoute
Comparator OSIRIS Unknown — —

Indications

allergic rhinitis